|Slideshows|June 19, 2020

Dispelling New Myths about Masks (and Shoes)

It’s a good idea to wear a mask while exercising and to thoroughly clean shoes to avoid bringing COVID-19 into the home, correct? Here are a few new myths your patients may be sharing.

The World Health Organization's COVID-19 Mythbusters page has been updated again and several of the newest misconceptions reflect the global shift toward less restrictive lifestyles. Surgical or cloth masks have their place in the effort to stem virus spread and you may need to help educate your primary care patients on when--and when not--to use them. The following slides highlight new fictions posted the the WHO page and recap several stubborn ones.

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Related to this article

October 23rd, 2026

Menopause Diagnoses Documented in Just 7.8% of Midlife Women's Outpatient Visits, Study Finds

TMS 2026: OB/GYN visits had nearly 4-fold higher odds of menopause coding than family medicine visits, with disparities by race and insurance, a study found.

October 23rd, 2026

More Frequent Physical Activity Linked to Fewer Perimenopause Symptoms in Global Study

TMS 2026: Women exercising at least 5 days a week reported lower perimenopause symptom scores across psychological, somatic, and urogenital domains.

October 22nd, 2026

Menopause Hormone Therapy Linked to Greater Weight Loss With Semaglutide in Real-World Study

TMS 2026: Menopause hormone therapy was associated with greater weight loss on semaglutide, but not sustained additional benefits with tirzepatide, in a new study.

October 21st, 2026

Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women

TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.

October 20th, 2026

Insulin Resistance May Partly Explain Higher Cardiovascular Risk After Premature Menopause

TMS 2026: In ARIC, menopause before age 40 was linked to higher CVD and CHD risk, with insulin resistance mediating about 19% of the association.

October 20th, 2026

Elinzanetant Linked to Broad Improvements in Sleep Disturbance in Women With Moderate-to-Severe Vasomotor Symptoms

TMS 2026: Post hoc OASIS 1 and 2 data show more women on elinzanetant reported improvement across all 8 PROMIS sleep disturbance items vs placebo at week 12.

October 20th, 2026

AI-Enhanced Virtual Reality Program Delivering CBT Shows Early Feasibility for Menopause Symptoms: TMS 2026

In a pilot study of 20 midlife women with vasomotor symptoms, an AI-enabled VR program delivering CBT showed early feasibility and acceptability.

October 19th, 2026

Capsule-Sponge Testing Could Help Close the Barrett’s Screening Gap: An Expert Q&A

Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and promise for primary care triage to endoscopy.

Dispelling New Myths about Masks (and Shoes)

Related to this article

Trending on Patient Care Online

Menopause Hormone Therapy Linked to Greater Weight Loss With Semaglutide in Real-World Study

Fezolinetant May Improve Depression, Anxiety Symptoms in Women With Menopausal VMS

Capsule-Sponge Testing Could Help Close the Barrett’s Screening Gap: An Expert Q&A

AI-Enhanced Virtual Reality Program Delivering CBT Shows Early Feasibility for Menopause Symptoms: TMS 2026

Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women